2017 – iCo Therapeutics

iCo Therapeutics Announces Third Quarter 2017 Financial Results

November 28, 2017, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)

ico_admin2019-07-04T03:28:49+00:00November 28th, 2017|2017|

November 22, 2017, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:

ico_admin2019-07-04T03:27:48+00:00November 22nd, 2017|2017|

September 7, 2017, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)

ico_admin2019-07-04T03:26:54+00:00September 7th, 2017|2017|

August 29, 2017, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)

ico_admin2019-07-04T03:26:01+00:00August 29th, 2017|2017|

August 4, 2017, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:

ico_admin2020-08-07T21:27:53+00:00August 4th, 2017|2017|

June 30, 2017, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:

ico_admin2019-07-04T03:23:21+00:00June 30th, 2017|2017|

Vancouver, British Columbia--(Newsfile Corp. - June 15, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB:

ico_admin2019-07-04T03:22:35+00:00June 15th, 2017|2017|

Vancouver, British Columbia--(Newsfile Corp. - June 12, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB:

ico_admin2019-07-04T03:21:42+00:00June 12th, 2017|2017|

Vancouver, British Columbia--(Newsfile Corp. - May 24, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB:

ico_admin2019-07-04T03:18:35+00:00May 24th, 2017|2017|

April 19, 2017, Vancouver, Canada — iCo Therapeutics (“iCo” or “the Company”) (TSX-V: ICO)

ico_admin2019-07-04T03:17:29+00:00April 19th, 2017|2017|